Individuals Coming Off Weight-Loss Injections Gain Back Pounds at a Quadrupled Rate Compared to Dieters

Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass at a significantly accelerated pace than those who end conventional lifestyle programs.

Findings released in a leading health publication shows that while overweight individuals frequently drop substantial amounts of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Individuals purchasing these drugs must be informed of the danger of quick rebound weight gain when the medication is stopped," warns lead investigator Dr. Susan Jebb.

Such speed of regain implies a reversion to starting weight within about a year and a half.

Comparing Therapies

The research, which looked at 37 of studies involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods.

Researchers note that individuals who shed pounds through dieting generally experience a less rapid weight regain—around 100 grams monthly—after stopping.

Understanding the Fast Regain

Doctors propose the mechanism of the jabs explains the heightened regain.

GLP-1 drugs mimic a natural hormone called GLP-1, which controls feelings of fullness.

"Long-term administration of the hormone levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication means hunger is uncontrolled, making binge eating much more probable."

A Chronic Disease?

Medical guidelines advise the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Many experts contend that, due to the significant potential of relapse, the treatment is often long-term.

This view is echoed by pharmaceutical companies, who note that the results "highlight the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.

Patient Testimonies

People who have discontinued the medication describe a intense return of hunger.

"I experienced a trigger that goes on and you become starving," described a patient.

The struggle is compounded if users have not developed lasting lifestyle or habit changes during treatment.

Growing Adoption

Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with demand being substantial.

• Adoption is higher among females compared to males.
• The middle-aged age group shows the greatest level of interest.
• Many obtain the medications through private healthcare rather than the NHS.

Finally, researchers emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a magic cure and long-term success hinges on integrated behavioural management.